In particular, in the more sensitive test procedure for GC, the correlation analyses showed associations between ERBB2 overexpression, tumor progression, high tumor grade, and the occurrence of an ERBB2 amplification or gain. The gene discussed is ERBB2; the disease is gastric cancer.